GANX
Gain TherapeuticsยทNASDAQ
--
--(--)
--
--(--)
GANX Profile
Gain Therapeutics, Inc.
A biotech company that develops novel allosteric binding sites and creating small molecule treatments
Biological Technology
06/26/2020
03/18/2021
NASDAQ Stock Exchange
20
12-31
Common stock
4800 Montgomery Lane
Suite 220 Bethesda
Maryland 20814
--
Gain Therapeutics, Inc., was incorporated in Delaware on June 26, 2020. The Company is a biotechnology company that develops novel small molecule therapies for the treatment of diseases in multiple therapeutic areas, including central nervous system (" CNS ") diseases, lysosomal storage disorders (" LSD "), metabolic disorders, and other diseases that can be targeted by protein degradation, such as oncology.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
